Kyverna Therapeutics, Inc. (KYTX) vs MapLight Therapeutics, Inc. (MPLT)

A side-by-side comparison of Kyverna Therapeutics, Inc. and MapLight Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Kyverna Therapeutics, Inc. logo
KYTX
Kyverna Therapeutics, Inc.
$384M
$6.31HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
MapLight Therapeutics, Inc. logo
MPLT
MapLight Therapeutics, Inc.
$397M
$9.35HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — KYTX vs MPLT

growth of $100 · dividends reinvested · last 1y
KYTX -19.1% (-19.1%/yr)MPLT -49.4% (-49.4%/yr)KYTX compounded faster over this window
50100150200Start $1002026$81$51
KYTX MPLT

KYTX vs MPLT: by the numbers

  • •MPLT is the larger company ($397M vs $384M market cap).

Metrics side by side

Valuation

MetricKYTXMPLT
P/B ratio2.321.14

Profitability

MetricKYTXMPLT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-92.20%-65.99%
ROIC-80.67%-69.35%

Go deeper

Full KYTX analysisFull MPLT analysisInteractive comparison tool

Dig into the metrics

Kyverna Therapeutics ROEMapLight Therapeutics ROEKyverna Therapeutics operating marginMapLight Therapeutics operating marginKyverna Therapeutics revenue growthMapLight Therapeutics revenue growthKyverna Therapeutics free cash flowMapLight Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.